PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+4.56%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$693M
(+7.9%)
Cap. Flow
+$371M
Cap. Flow
% of AUM
3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
293
New
45
Increased
130
Reduced
62
Closed
40
Top Buys
| 1 |
Intel
INTC
|
$84.5M |
| 2 |
Arch Capital
ACGL
|
$77.1M |
| 3 |
HCA Healthcare
HCA
|
$66M |
| 4 |
Altria Group
MO
|
$58.7M |
| 5 |
Merck
MRK
|
$51.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$171M |
| 2 |
VR
Validus Hold Ltd
VR
|
$167M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$74.5M |
| 4 |
Nektar Therapeutics
NKTR
|
$60.8M |
| 5 |
UnitedHealth
UNH
|
$60.2M |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Financials | 23.76% |
| 3 | Healthcare | 20.17% |
| 4 | Communication Services | 10.96% |
| 5 | Industrials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
ResMed
RMD
$40.6B
| $16.4M | 0.17% |
+166,592
| New | +$16.4M |
|
152
PNC Financial Services
PNC
$80.5B
| $15.7M | 0.16% |
103,793
-4,874
| -4% | -$737K |
|
153
Toronto Dominion Bank
TD
$127B
| $15.4M | 0.16% |
235,860
+1,350
| +0.6% | +$88K |
|
154
IAC Inc
IAC
$2.98B
| $14.9M | 0.15% |
531,967
+37,965
| +8% | +$1.06M |
|
155
Eli Lilly
LLY
$652B
| $14.6M | 0.15% |
+189,000
| New | +$14.6M |
|
|
QVCGA
156
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $14.4M | 0.14% |
11,746
+34
| +0.3% | +$41.5K |
|
|
ALXN
157
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $13.9M | 0.14% |
125,000
-441,371
| -78% | -$49.2M |
|
158
Cisco
CSCO
$264B
| $13.9M | 0.14% |
+325,200
| New | +$13.9M |
|
|
FMI
159
DELISTED
Foundation Medicine, Inc.
FMI
| $13.6M | 0.14% |
+173,000
| New | +$13.6M |
|
160
Assembly Biosciences
ASMB
$183M
| $13.5M | 0.14% |
22,942
+10,417
| +83% | +$6.14M |
|
161
Manchester United
MANU
$2.71B
| $13.3M | 0.13% |
714,835
+48,639
| +7% | +$906K |
|
162
Aurinia Pharmaceuticals
AUPH
$1.63B
| $13M | 0.13% |
2,500,000
+200,000
| +9% | +$1.04M |
|
163
Regeneron Pharmaceuticals
REGN
$60.8B
| $12.9M | 0.13% |
37,500
-2,500
| -6% | -$861K |
|
164
Supernus Pharmaceuticals
SUPN
$2.58B
| $12.6M | 0.13% |
275,000
+75,000
| +38% | +$3.44M |
|
165
Wolfspeed
WOLF
$196M
| $12.5M | 0.13% |
309,243
-124,957
| -29% | -$5.04M |
|
166
Mastercard
MA
$528B
| $12.3M | 0.12% |
70,227
+3,373
| +5% | +$591K |
|
|
FRC
167
DELISTED
First Republic Bank
FRC
| $12.2M | 0.12% |
131,799
+3,528
| +3% | +$327K |
|
168
Ares Capital
ARCC
$15.8B
| $11.6M | 0.12% |
731,732
+15,000
| +2% | +$238K |
|
169
Centene
CNC
$14.2B
| $11.5M | 0.12% |
215,000
-600,000
| -74% | -$32M |
|
170
Thermo Fisher Scientific
TMO
$186B
| $11.4M | 0.12% |
55,422
+35,603
| +180% | +$7.35M |
|
|
TSRO
171
DELISTED
TESARO, Inc.
TSRO
| $11.4M | 0.12% |
200,000
+60,000
| +43% | +$3.43M |
|
172
Gilead Sciences
GILD
$143B
| $11.3M | 0.11% |
+150,000
| New | +$11.3M |
|
173
Littelfuse
LFUS
$6.51B
| $11.1M | 0.11% |
53,354
+24,235
| +83% | +$5.04M |
|
174
Take-Two Interactive
TTWO
$44.2B
| $10.9M | 0.11% |
111,227
+33,536
| +43% | +$3.28M |
|
175
Revvity
RVTY
$10.1B
| $10.7M | 0.11% |
141,887
| – | – |
|